TABLE 2.
Species or species complex | Antifungal agentb | MIC (μg/ml) |
Calculated statistical ECV (μg/ml)c |
|||
---|---|---|---|---|---|---|
Range | Moded | ≥95% | ≥97.5% | ≥99% | ||
F. verticillioides | AMB | 0.5–16 | 2 | 4 | 4 | 4 |
ITR | 1–≥16 | 16 | ND | ND | ND | |
POS | ≤0.25–≥16 | 0.5 | 2 | 2 | 2 | |
VOR | 0.5–≥16 | 2 | 4 | 4 | 8 | |
F. oxysporum SC | AMB | ≤0.25–16 | 2 | 4 | 8 | 8 |
ITR | 1–≥16 | 16 | 32 | 32 | 32 | |
POS | 0.5–16 | 2 | 8 | 8 | 8 | |
VOR | 0.5–≥16 | 4 | 8 | 16 | 16 | |
F. solani SC | AMB | ≤0.25–16 | 2 | 4 | 8 | 8 |
ITR | 0.5–≥16 | 16 | 16 | 32 | 32 | |
POS | 1–≥16 | 8 | 32 | 32 | 32 | |
VOR | 0.5–≥16 | 8 | 16 | 32 | 32 |
ECVs were defined for pooled distributions for ≥100 isolates from ≥3 laboratories using the methodology of CLSI document M38-A2 (25, 35).
AMB, amphotericin B; ITR, itraconazole; POS, posaconazole; VOR, voriconazole.
Calculated ECVs comprising ≥95%, ≥97.5%, and ≥99% of the statistically modeled population. ND, not determined (due to insufficient data).
MIC most frequently obtained for each distribution.